| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Mar 2026 | 2 Mar 2026 |
| Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/03/2026 inter alia to consider and approve 1. To consider and approve subject to shareholders approval the subdivision (stock split) of existing equity shares of the Company and to fix the Record Date for the same if approved. 2. To consider and recommend to increase in Authorized Share Capital and consequential Alteration in Capital Clause of the Memorandum of Association of the Company. 3. To consider and approve subject to shareholders approval the issue of Bonus Equity Shares to the equity shareholders of the Company on such terms and in such proportion as may be determined by the Board of Directors. 4. Any other business(s) with permission of the Chair if any. You are requested to take the above information on your record. Thanking You. Anlon Healthcare Limited has informed the Exchange that the Board of Directors at its meeting held on March 06, 2026, has considered and approved 1. Sub-division of equity shares from face value of Rs.10/- each to face value of Rs.02/- each., 2. Alteration of Capital Clause of the Memorandum of Association of the Company Subsequent to Sub-Division of Equity Shares, 3. Increase in Authorized Share Capital and Consequent Alteration to the Capital Clause of the Memorandum of Association, 4. Issue of Bonus Shares in the ratio of 1:1. (As per BSE announcement dated on :06.03.2026) | ||
| Board Meeting | 9 Feb 2026 | 3 Feb 2026 |
| Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. To consider and approve the Unaudited Standalone Financial Results along with Limited Review Report by Auditor thereon of the Company for the quarter and nine months ended on December 31 2025. 2. Any other business(s) with permission of the Chair if any. Kindly take the same on your record. Thank you. We have attached herewith outcome of Board Meeting with other matters considered and approved. Kindly take the same on your record. Thank you. We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your recorf. Thank you. (As Per BSE Announcement Dated on:09.02.2026) | ||
| Board Meeting | 5 Dec 2025 | 5 Dec 2025 |
| We have attached herewith Outcome of Board Meeting held on Friday, December 05, 2025. Kindly take the same on your record. Thank you. | ||
| Board Meeting | 11 Nov 2025 | 6 Nov 2025 |
| Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve 1. To consider and approve the Unaudited Standalone Financial Results along with Limited Review Report by Auditor thereon of the Company for the quarter and half year ended on September 30 2025. 2. Any other business(s) with permission of the Chair if any. You are requested to take the above information on your record. Thanking You. We have attached herewith outcome of Board Meeting as per Reg. 30 and 33 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you. (As per BSE Announcement dated on: 11.11.2025) | ||
| Board Meeting | 16 Oct 2025 | 13 Oct 2025 |
| Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2025 inter alia to consider and approve 1. To consider and approve the expansion plan of the Companys business operation through existing facility expansion and/or acquisition strategy including: - Review of existing market opportunities and competitive landscape - Evaluation of expansion options including capital expenditure requirements and potential returns arising therefrom - Discussion on acquisition targets valuation and integration plans aligned with the existing business operations - To evaluate the pros and cons of expanding existing facilities versus acquisition strategy and the long-term benefits arising therefrom of each of these options for the shareholders. 2. Any other business(s) with permission of the Chair if any. You are requested to take the above information on your record. Thanking You. Respected Sir/Madam, We have attached herewith Outcome of Board Meeting. Kindly take the same on your record. Thank you. (As Per BSE Announcement Dated on:16.10.2025) | ||
| Board Meeting | 27 Sep 2025 | 24 Sep 2025 |
| Inter alia, to consider and approve:- 1. To consider and approve proposal for purchase of immovable property (Commercial Office) situated at Golden Crown, New 150 Feet Ring Road, Opp. IOC Petrol Pump, Near Parsana Chowk, Rajkot - 360005, Gujarat. 2. Any other business(s) with permission of Chair, if any. We have attached herewith outcome of Board Meeting held on Saturday, September 27, 2025. Kindly take the same on your record. Thank you. (As Per BSE Announcement Dated on: 27/09/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
